| Number of female leprosy new cases WHO | WHO | 0 |
| New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population WHO | WHO | 0 |
| Number of non-autochthonous leprosy cases WHO | WHO | 0 |
| New leprosy case detection rate per 1 000 000 population WHO | WHO | 0 |
| Leprosy - Number of cases registered for treatment WHO | WHO | 0 |
| Leprosy registered prevalence rate per 1 000 000 population WHO | WHO | 0 |
| Number of new G2D leprosy cases WHO | WHO | 0 |
| Leprosy - New leprosy cases with G2D rate per 1 000 000 population WHO | WHO | 0 |
| Leprosy - Number of new leprosy cases among children (less than 15 years of age) WHO | WHO | 0 |
| Number of new leprosy cases with G2D among children (less than 15 years of age) WHO | WHO | 0 |
| Number of new leprosy cases WHO | WHO | 0 |
| New chronic hepatitis B (HBV) infections (number) WHO | WHO | – |
| Hepatitis - Deaths caused by chronic hepatitis B and C (per 100 000 population) WHO | WHO | −37.5% |
| People living with chronic hepatitis B (HBV) (number) WHO | WHO | +0.4% |
| Prevalence of chronic hepatitis B (HBV) in the general population (%) WHO | WHO | −10.8% |
| New chronic hepatitis C (HCV) infections (number) WHO | WHO | – |
| People living with chronic hepatitis C (HCV) including cured (all ages) (adjusted number) WHO | WHO | +5.5% |
| People living with chronic hepatitis C (HCV) (number) WHO | WHO | −46.3% |
| Prevalence of chronic hepatitis C (HCV) ) in the general population (%) WHO | WHO | −52.9% |
| Hepatitis - Deaths caused by chronic hepatitis B and C WHO | WHO | −22.2% |
| Persons on chronic hepatitis B (HBV) treatment (number) WHO | WHO | +33.3% |
| Chronic hepatitis B (HBV) treatment rate as percentage of diagnosed (%) WHO | WHO | +26.2% |
| Chronic hepatitis B (HBV) treatment rate as percentage of total infected (%) WHO | WHO | +32.6% |
| Persons on chronic hepatitis C (HCV) treatment, cumulative (number) WHO | WHO | +605.3% |
| Chronic hepatitis C (HCV) cumulative treatment rate as percentage of total infected, including cured (%) WHO | WHO | +568.3% |
| Persons initiated chronic hepatitis C(HCV) treatment (number) WHO | WHO | −65.8% |
| Chronic hepatitis C (HCV) treatment rate as percentage of diagnosed (%) WHO | WHO | +374.3% |
| Chronic hepatitis B (HBV) infected persons diagnosed (number) WHO | WHO | +5.7% |
| Chronic hepatitis B (HBV) diagnosis coverage as a percentage of infected (%) WHO | WHO | +5.2% |
| Chronic hepatitis C (HCV) infected persons diagnosed, including cured (number) WHO | WHO | +48.6% |
| Chronic hepatitis C (HCV) infected persons diagnosed (number) WHO | WHO | −48% |
| Chronic hepatitis C (HCV) diagnosis coverage as percentage of total HCV infected, including cured (%) WHO | WHO | +40.9% |
| Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) WHO | WHO | −1.1% |
| Physical activity policies for activie societies WHO | WHO | 0 |
| Physical activity policies focused on active systems WHO | WHO | 0% |
| Number of imported cases of visceral leishmaniasis reported WHO | WHO | 0 |
| Number of under-five deaths WHO | WHO | 0% |
| Under-five mortality rate (probability of dying by age 5 per 1000 live births) WHO | WHO | −3.8% |
| Stillbirth rate (per 1000 total births) WHO | WHO | 0% |
| Number of deaths among children ages 5 to 9 years WHO | WHO | 0 |
| Mortality rate among children ages 5 to 9 years (per 1000 children aged 5) WHO | WHO | 0% |
| Number of neonatal deaths WHO | WHO | 0% |
| Neonatal mortality rate (per 1000 live births) WHO | WHO | −7.7% |
| Number of deaths among children 5 to 14 years of age WHO | WHO | 0 |
| Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) WHO | WHO | 0% |
| Number of women of reproductive age (aged 15-49 years) with anaemia (thousands) WHO | WHO | +3.3% |
| Number of infant deaths WHO | WHO | 0% |
| Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) WHO | WHO | −4% |
| Number of deaths among adolescents (10 to 19 years of age) WHO | WHO | 0 |
| Adolescent mortality rate (per 1 000 age specific cohort) WHO | WHO | 0% |
| Hepatitis B surface antigen (HBsAg) prevalence (%) WHO | WHO | −0.1 |
| Childhood cancer survival for lymphoid leukaemia, age-standardized 5-year net survival (%) WHO | WHO | – |
| International Health Regulations core capacity scores, SPAR version, 2nd edition WHO | WHO | +8% |
| Deaths by age, sex and legal marital status Eurostat | Eurostat | – |
| HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%) WHO | WHO | −3.5% |
| Polio (Pol3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Pertussis - number of reported cases WHO | WHO | −27 |
| Total tetanus - number of reported cases WHO | WHO | 0 |
| Yellow fever - number of reported cases WHO | WHO | 0 |
| Rubella - number of reported cases WHO | WHO | 0 |
| Diphtheria - number of reported cases WHO | WHO | 0 |
| Japanese encephalitis - number of reported cases WHO | WHO | 0 |
| Mumps - number of reported cases WHO | WHO | +2 |
| Congenital Rubella Syndrome - number of reported cases WHO | WHO | 0 |
| Neonatal tetanus - number of reported cases WHO | WHO | 0 |
| Measles - number of reported cases WHO | WHO | 0 |
| Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%) WHO | WHO | −3.1% |
| Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) WHO | WHO | +90 |
| Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%) WHO | WHO | −1% |
| Hib (Hib3) immunization coverage among 1-year-olds (%) WHO | WHO | −1% |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) WHO | WHO | +1% |
| Inactivated first-dose polio vaccine (IPV1) immunization coverage among 1-year-olds (%) (WUENIC) WHO | WHO | 0% |
| Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) WHO | WHO | 0% |
| Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC) WHO | WHO | 0% |
| Adopted written national policy on alcohol WHO | WHO | 0% |
| Action Plan for implementation of alcohol policy WHO | WHO | 0% |
| Alcoholic beverage legally defined WHO | WHO | 0% |
| National legislation to prevent illegal alcohol WHO | WHO | 0% |
| Adopted written national policy on alcohol, year revised WHO | WHO | – |
| Standard drink defined WHO | WHO | 0 |
| National drinking guidelines WHO | WHO | – |
| National legislation to prevent illegal alcohol sales WHO | WHO | 0% |
| Government monopoly on production WHO | WHO | 0 |
| Government monopoly on retail sales WHO | WHO | 0 |
| Detection of marketing infringements WHO | WHO | +1 |
| Penalties for marketing infringements WHO | WHO | – |
| Off-premise sales restrictions on days WHO | WHO | 0 |
| Off-premise sales restrictions on hours WHO | WHO | 0 |
| Off-premise sales restrictions on places WHO | WHO | 0 |
| Off-premise sales restrictions on outlet density WHO | WHO | 0 |
| On-premise sales restrictions on days WHO | WHO | 0% |
| On-premise sales restrictions on hours WHO | WHO | 0% |
| On-premise sales restrictions on places WHO | WHO | 0% |
| On-premise sales restrictions on outlet density WHO | WHO | 0 |
| On-premise sales restrictions to intoxicated persons WHO | WHO | 0% |
| Server training WHO | WHO | 0 |
| Remote ordering of alcohol regulated WHO | WHO | – |
| Level of taxation adjusted for inflation WHO | WHO | 0 |
| Duty paid or excise stamp on alcohol container WHO | WHO | 0 |
| Number of standard alcoholic drinks displayed on containers WHO | WHO | 0 |
| Alcohol content displayed on containers WHO | WHO | 0% |
| Health warning labels on pregnancy WHO | WHO | 0 |
| Health warning labels on under-age drinking WHO | WHO | 0 |
| Health warning labels on drink-driving WHO | WHO | 0 |
| Health warning labels on alcohol advertising WHO | WHO | 0 |
| Health warning labels on alcohol containers WHO | WHO | 0 |
| Legal blood alcohol concentration (BAC) limits WHO | WHO | 0% |
| Age limits off-premise sales WHO | WHO | 0% |
| Random breath testing (RBT) use WHO | WHO | 0% |
| Penalties for drink driving WHO | WHO | – |
| Sobriety checkpoints WHO | WHO | 0% |
| Graduated licensing WHO | WHO | 0 |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), by beverage type WHO | WHO | 0% |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average WHO | WHO | 0% |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol), three-year average WHO | WHO | 0% |
| Alcohol, tourist consumption (in litres of pure alcohol), three-year average WHO | WHO | 0 |
| Alcohol, consumption of pure alcohol by type of beverage (%) WHO | WHO | 0% |
| Cancer survival for those diagnosed with breast cancer, 5-year net survival (%) WHO | WHO | – |
| Number of imported cases of cutaneous leishmaniasis reported WHO | WHO | 0 |
| Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2), three-year average WHO | WHO | 0% |
| Low birth weight number (in thousands) WHO | WHO | 0% |
| Low birth weight prevalence (%) WHO | WHO | 0% |
| Late foetal deaths by mother's age Eurostat | Eurostat | −33.3% |
| Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) (%) WHO | WHO | +3.2% |
| Underweight among adults, BMI < 18.5 kg/m2 (crude estimate) (%) WHO | WHO | 0% |
| Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) (%) WHO | WHO | −0.4% |
| Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) (%) WHO | WHO | 0% |
| Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) (%) WHO | WHO | 0% |
| Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) (%) WHO | WHO | +0.6% |
| Proportion of population with primary reliance on clean fuels and technologies for cooking (%) WHO | WHO | 0% |
| Births attended by skilled health personnel (%) WHO | WHO | 0% |
| Current health expenditure (CHE) per capita in US$ WHO | WHO | +13% |
| Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%) WHO | WHO | +2.4% |
| External health expenditure (EXT) as percentage of current health expenditure (CHE) (%) WHO | WHO | 0 |
| Domestic general government health expenditure (GGHE-D) per capita in US$ WHO | WHO | +8.7% |
| Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%) WHO | WHO | −3.8% |
| Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%) WHO | WHO | −1.6% |
| Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%) WHO | WHO | −4.3% |
| Out-of-pocket expenditure (OOP) per capita in US$ WHO | WHO | +42.4% |
| Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%) WHO | WHO | +26% |
| Domestic private health expenditure (PVT-D) per capita in US$ WHO | WHO | +25.1% |
| Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%) WHO | WHO | +10.7% |
| Adolescent birth rate (per 1000 women) WHO | WHO | 0 |
| Medical doctors (per 10,000) WHO | WHO | +1.4% |
| Nursing and midwifery personnel (per 10,000) WHO | WHO | +4.7% |
| Dentists (per 10,000) WHO | WHO | +4.9% |
| Pharmacists (per 10,000) WHO | WHO | 0% |
| Reported number of people requiring interventions against NTDs WHO | WHO | 0 |
| Tobacco MPOWER Protect people: P2 smoke-free places, additional characteristics WHO | WHO | 0% |
| Tobacco Monitor: population-based national surveys, tobacco use and smoking, prevalence WHO | WHO | – |
| Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N) WHO | WHO | 0 |
| Tobacco Monitor: population-based national surveys, tobacco use and smoking WHO | WHO | – |
| Physiotherapists (number) WHO | WHO | +1% |
| Pharmacists (number) WHO | WHO | +1.3% |
| Pharmaceutical Technicians and Assistants (number) WHO | WHO | – |
| Dentists (number) WHO | WHO | +6.1% |
| Nursing and midwifery personnel (number) WHO | WHO | +6% |
| Nursing personnel (number) WHO | WHO | +6% |
| Midwifery personnel (number) WHO | WHO | +5.9% |
| Nursing personnel (%) WHO | WHO | +3.6% |
| Medical doctors (number) WHO | WHO | +2.7% |
| Generalist medical practitioners (number) WHO | WHO | 0% |
| Specialist medical practitioners (number) WHO | WHO | +3.7% |
| Medical doctors not further defined (number) WHO | WHO | +6.8% |
| Medical doctors (%) WHO | WHO | −1.3% |
| Estimate of current cigarette smoking prevalence (%) (age-standardized) WHO | WHO | +1% |
| Number of current cigarette smokers, estimate WHO | WHO | 0% |
| Estimate of current tobacco smoking prevalence (%) (age-standardized rate) WHO | WHO | −0.9% |
| Estimate of current tobacco use prevalence (%) (age-standardized) WHO | WHO | +0.3% |
| Estimate of current cigarette smoking prevalence (%) WHO | WHO | +0.4% |
| Estimate of current tobacco smoking prevalence (%) WHO | WHO | −1.2% |
| Sugar-content of beverage (g/100ml) WHO | WHO | – |
| Primary data availability for UHC Service Coverage Index (SDG 3.8.1) (%) WHO | WHO | – |
| UHC Service Coverage Index (SDG 3.8.1) WHO | WHO | +1.4% |
| UHC Service Coverage sub-index on service capacity and access WHO | WHO | 0% |
| UHC Service Coverage sub-index on infectious diseases WHO | WHO | 0% |
| UHC Service Coverage sub-index on noncommunicable diseases WHO | WHO | 0% |
| UHC Service Coverage sub-index on reproductive, maternal, newborn and child health WHO | WHO | 0% |
| HIV-positive TB patients on ART (antiretroviral therapy) (%) WHO | WHO | – |
| TB patients with known HIV status (%) WHO | WHO | +81.8% |
| Tested TB patients HIV-positive (%) WHO | WHO | – |
| Treatment success rate: new TB cases WHO | WHO | 0% |
| Treatment success rate: previously treated TB cases WHO | WHO | −100 |
| Treatment success rate: HIV-positive TB cases WHO | WHO | – |
| New cases tested for RR-/MDR-TB (%) WHO | WHO | −25% |
| Previously treated cases tested for RR-/MDR-TB (%) WHO | WHO | 0% |
| Cases started on MDR-TB treatment WHO | WHO | 0 |
| Confirmed cases of RR-/MDR-TB WHO | WHO | 0 |
| Tuberculosis - new and relapse cases WHO | WHO | 0% |
| Tuberculosis treatment coverage WHO | WHO | 0% |
| Incidence of tuberculosis (per 100 000 population per year) WHO | WHO | 0% |
| Number of incident tuberculosis cases WHO | WHO | 0% |
| Hypertension: diagnosis coverage among adults aged 30-79 with hypertension, age-standardized (%) WHO | WHO | +0.6% |
| Hypertension: diagnosis coverage among adults aged 30-79 with hypertension, crude (%) WHO | WHO | +1.7% |
| Hypertension among adults aged 30-79 years, prevalence, age-standardized WHO | WHO | −0.8% |
| Hypertension among adults aged 30-79 years, prevalence, crude WHO | WHO | +1% |
| Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%) WHO | WHO | +1.2% |
| Hypertension treatment coverage among adults aged 30-79 with hypertension, crude (%) WHO | WHO | +1.2% |
| Prevalence of diabetes, age-standardized WHO | WHO | 0% |
| Prevalence of diabetes, crude WHO | WHO | +1.8% |
| Diabetes treatment coverage, age-standardized WHO | WHO | +0.3% |
| Diabetes treatment coverage, crude WHO | WHO | +0.6% |
| Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%) WHO | WHO | −0.7% |
| Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate) WHO | WHO | 0% |
| Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate) WHO | WHO | −2% |
| Food safety IHR (%) WHO | WHO | – |
| Total alcohol consumption per capita, female (liters of pure alcohol, projected estimates, female 15+ years of age) World Development Indicators | World Development Indicators | −13% |
| Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age) World Development Indicators | World Development Indicators | −12.4% |
| Total alcohol consumption per capita, male (liters of pure alcohol, projected estimates, male 15+ years of age) World Development Indicators | World Development Indicators | −12.6% |
| Prevalence of anemia among women of reproductive age (% of women ages 15-49) World Development Indicators | World Development Indicators | +3.8% |
| Prevalence of anemia among children (% of children ages 6-59 months) World Development Indicators | World Development Indicators | +2.9% |
| Prevalence of anemia among non-pregnant women (% of women ages 15-49) World Development Indicators | World Development Indicators | +3.8% |
| Number of deaths ages 5-9 years World Development Indicators | World Development Indicators | 0 |
| Number of deaths ages 10-14 years World Development Indicators | World Development Indicators | 0 |
| Number of deaths ages 15-19 years World Development Indicators | World Development Indicators | 0% |
| Number of deaths ages 20-24 years World Development Indicators | World Development Indicators | 0% |
| Number of infant deaths World Development Indicators | World Development Indicators | 0% |
| Number of under-five deaths World Development Indicators | World Development Indicators | 0% |
| Number of neonatal deaths World Development Indicators | World Development Indicators | 0% |
| Probability of dying among children ages 5-9 years (per 1,000) World Development Indicators | World Development Indicators | 0% |
| Probability of dying among adolescents ages 10-14 years (per 1,000) World Development Indicators | World Development Indicators | 0% |
| Probability of dying among adolescents ages 15-19 years (per 1,000) World Development Indicators | World Development Indicators | 0% |
| Probability of dying among youth ages 20-24 years (per 1,000) World Development Indicators | World Development Indicators | 0% |
| Mortality rate, under-5 (per 1,000 live births) World Development Indicators | World Development Indicators | −3.7% |
| Mortality rate, under-5, female (per 1,000 live births) World Development Indicators | World Development Indicators | −4.3% |
| Mortality rate, under-5, male (per 1,000 live births) World Development Indicators | World Development Indicators | −3.3% |
| Mortality rate, neonatal (per 1,000 live births) World Development Indicators | World Development Indicators | 0% |
| People using safely managed drinking water services (% of population) World Development Indicators | World Development Indicators | 0% |
| Immunization, HepB3 (% of one-year-old children) World Development Indicators | World Development Indicators | 0% |
| Immunization, DPT (% of children ages 12-23 months) World Development Indicators | World Development Indicators | 0% |
| Immunization, measles (% of children ages 12-23 months) World Development Indicators | World Development Indicators | −1% |
| Hospital beds (per 1,000 people) World Development Indicators | World Development Indicators | −11% |
| Nurses and midwives (per 1,000 people) World Development Indicators | World Development Indicators | +3.7% |
| Physicians (per 1,000 people) World Development Indicators | World Development Indicators | +0.7% |
| Specialist surgical workforce (per 100,000 population) World Development Indicators | World Development Indicators | +37.9% |
| Number of maternal deaths World Development Indicators | World Development Indicators | 0 |
| Lifetime risk of maternal death (1 in: rate varies by country) World Development Indicators | World Development Indicators | +54.9% |
| Lifetime risk of maternal death (%) World Development Indicators | World Development Indicators | −35.4% |
| Prevalence of anemia among pregnant women (%) World Development Indicators | World Development Indicators | 0% |
| Prevalence of current tobacco use (% of adults) World Development Indicators | World Development Indicators | +0.6% |
| Prevalence of current tobacco use, females (% of female adults) World Development Indicators | World Development Indicators | +1.6% |
| Prevalence of current tobacco use, males (% of male adults) World Development Indicators | World Development Indicators | −0.6% |
| Number of surgical procedures (per 100,000 population) World Development Indicators | World Development Indicators | – |
| Births attended by skilled health staff (% of total) World Development Indicators | World Development Indicators | 0% |
| Low-birthweight babies (% of births) World Development Indicators | World Development Indicators | +0.3% |
| Diabetes prevalence (% of population ages 20 to 79) World Development Indicators | World Development Indicators | +87% |
| Maternal mortality ratio (modeled estimate, per 100,000 live births) World Development Indicators | World Development Indicators | −35.3% |
| People using safely managed sanitation services, rural (% of rural population) World Development Indicators | World Development Indicators | 0% |
| People using safely managed sanitation services, urban (% of urban population) World Development Indicators | World Development Indicators | 0% |
| People using safely managed sanitation services (% of population) World Development Indicators | World Development Indicators | 0% |
| Tuberculosis treatment success rate (% of new cases) World Development Indicators | World Development Indicators | 0% |
| Tuberculosis case detection rate (%, all forms) World Development Indicators | World Development Indicators | 0% |
| Incidence of tuberculosis (per 100,000 people) World Development Indicators | World Development Indicators | −1.7% |
| UHC service coverage index World Development Indicators | World Development Indicators | +1.3% |
| Current health expenditure (% of GDP) World Development Indicators | World Development Indicators | +5.2% |
| Current health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +14.5% |
| Current health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +9.8% |
| Domestic general government health expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | −3.2% |
| Domestic general government health expenditure (% of GDP) World Development Indicators | World Development Indicators | +1.8% |
| Domestic general government health expenditure (% of general government expenditure) World Development Indicators | World Development Indicators | −2.7% |
| Domestic general government health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +10.8% |
| Domestic general government health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +6.3% |
| Out-of-pocket expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | +24.2% |
| Out-of-pocket expenditure per capita (current US$) World Development Indicators | World Development Indicators | +42.1% |
| Out-of-pocket expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +36.3% |
| Domestic private health expenditure (% of current health expenditure) World Development Indicators | World Development Indicators | +8.8% |
| Domestic private health expenditure per capita (current US$) World Development Indicators | World Development Indicators | +24.6% |
| Domestic private health expenditure per capita, PPP (current international $) World Development Indicators | World Development Indicators | +19.5% |
| Mortality rate, adult, female (per 1,000 female adults) World Development Indicators | World Development Indicators | −0.5% |
| Mortality rate, adult, male (per 1,000 male adults) World Development Indicators | World Development Indicators | −0.2% |
| Mortality rate, infant, female (per 1,000 live births) World Development Indicators | World Development Indicators | −4.3% |
| Mortality rate, infant (per 1,000 live births) World Development Indicators | World Development Indicators | −3.8% |
| Mortality rate, infant, male (per 1,000 live births) World Development Indicators | World Development Indicators | −3.4% |
| Life expectancy at birth, female (years) World Development Indicators | World Development Indicators | 0% |
| Life expectancy at birth, total (years) World Development Indicators | World Development Indicators | 0% |
| Survival to age 65, female (% of cohort) World Development Indicators | World Development Indicators | 0% |
| Survival to age 65, male (% of cohort) World Development Indicators | World Development Indicators | 0% |
| Population ages 75-79, female (% of female population) World Development Indicators | World Development Indicators | +2.8% |
| Population ages 75-79, male (% of male population) World Development Indicators | World Development Indicators | +2% |
| Population ages 80 and above, female (% of female population) World Development Indicators | World Development Indicators | +2.6% |
| Population ages 80 and above, male (% of male population) World Development Indicators | World Development Indicators | +5.3% |
| Hospital beds (per 10 000 population) WHO | WHO | −2.7% |
| Tobacco Enforce bans: E1 direct advertising WHO | WHO | 0 |
| Population with primary reliance on polluting fuels and technologies for cooking (in millions) WHO | WHO | 0 |
| Proportion of population with primary reliance on polluting fuels and technologies for cooking (%) WHO | WHO | 0 |
| Population with primary reliance on clean fuels and technologies for cooking (in millions) WHO | WHO | 0% |
| Tobacco MPOWER Protect people: P1 smoke-free places (national legislation) WHO | WHO | 0 |
| Tobacco Enforce bans: E2 indirect advertising WHO | WHO | 0 |
| Tobacco Enforce bans: E3 indirect advertising, additional bans WHO | WHO | 0 |
| Tobacco Warning: W1a cigarette packaging health warnings WHO | WHO | 0 |
| Tobacco Warning: W1b smoked tobacco packaging health warnings WHO | WHO | 0 |
| Tobacco Warning: W1c smokeless tobacco packaging health warnings WHO | WHO | 0 |
| Tobacco Warning: W2a cigarette packaging health warnings, other characteristics WHO | WHO | 0 |
| Tobacco Warning: W2b smoked tobacco packaging health warnings, other characteristics WHO | WHO | 0 |
| Tobacco Warning: W2c smokeless tobacco packaging health warnings, other characteristics WHO | WHO | 0 |
| Congenital syphilis number of cases, reported WHO | WHO | 0 |
| Congenital syphilis rate per 100 000 live births, reported WHO | WHO | 0 |
| Tobacco Warning: W3 anti-tobacco mass-media campaigns WHO | WHO | 0 |
| Tobacco Offer help: O1 Support for treatment of tobacco dependence / Availability of smoking cessation support WHO | WHO | 0 |